NanoViricides registers Phase II NV-387 oral trial in Pan African database
NanoViricides (NNVC) said its Phase II clinical trial of NV-387 oral gummies to treat the current Bundibugyo Ebola outbreak has been registered in the Pan African Clinical Trials Database and is ready to go.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.